Results 121 to 130 of about 1,163 (152)

Predictors and Outcomes of Oral Anticoagulant Deprescribing in Geriatric Inpatients With Atrial Fibrillation: A Retrospective Multicenter Cohort Study [PDF]

open access: yes
Bo, Mario   +6 more
core   +1 more source

Deprescription in elderly patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2020
The Primary aim is to verify physicians' adherence to the 2016 Italian diabetes guidelines therapeutic targets, and their habits on deprescription in elderly persons with Type 2 Diabetes Mellitus (T2DM). Secondary aims are the assessment of the potential impact of the targets' changes in 2018 Italian guidelines, and the outcomes of deprescription in ...
Giovanni Antonio Silverii   +2 more
exaly   +3 more sources

Control Task Analysis of the Deprescription Process: A Pilot Study

Proceedings of the Human Factors and Ergonomics Society, 2023
Deprescription is the process by which a physician supervises a patient’s withdrawal or dose reduction of a given medication due to side effects or diminishing efficacy. Prior studies on the process of deprescription have resulted in a number of models, two of which are used in this pilot study alongside the decision ladder to construct a novel ...
Robert G Wahler Jr
exaly   +2 more sources

Implementation of Proton Pump Inhibitor Deprescription Protocol in Geriatric Residents

Annals of Pharmacotherapy, 2018
Background: Deprescribing is a recommended intervention to reduce morbidity and mortality caused by polypharmacy in older residents. However, a lack of definite deprescription guidelines and evidence of clinically meaningful outcomes complicates or precludes the practicality of such an approach.
Ovadyah, Avraham, Michael, Biglow
exaly   +3 more sources

A prudent deprescription model

Medicina Clínica (English Edition), 2015
The therapeutic structure of health systems relies heavily on medical prescription, which generates a marked tendency to add drugs to a patient's medical history. There is an absence of incentives for professionals to reassess prescriptions and withdraw those with a negative or neutral risk/benefit.
Joaquín, Hortal Carmona   +2 more
openaire   +2 more sources

Deprescription in Advanced Cancer Patients Referred to Palliative Care

Journal of Pain & Palliative Care Pharmacotherapy, 2016
In palliative care, drugs are considered futile if they do not have a short-term benefit in symptom control or quality of life. The authors examined pharmacotherapy prescribed for patients referred to palliative care to identify futile drugs. This was a retrospective analysis of patients referred over 6 months, focusing on the prescription of gastric ...
Liliana, Oliveira   +4 more
openaire   +2 more sources

Deprescription in elderly: A spotlight on pharmacoeconomic aspect

Clinical and Experimental Pharmacology and Physiology, 2019
AbstractAging is a complex process and many factors in the elderly, especially multiple diseases and related unnecessary drug use, support a deprescription approach to this age group to save money and health cost. In this review, we have searched for studies related to the pharmacoeconomic aspect of this deprescription approach in the elderly.
openaire   +2 more sources

Home - About - Disclaimer - Privacy